08/11/2024  17:32:00 Diferencia -0.40 Volumen Bid17:32:00 Ask17:32:00 Capitalización de mecado Dividendo A. P/E Ratio
79.13CHF -0.50% 497,631
Volumen de negocios: 39.46 millones
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 210.88 mil millonesCHF 3.80% 18.63

Descripción de negocio

Nestlé is a science-based Nutrition, Health and Wellness company. The creation of Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences reinforced this strategic direction and focus on helping consumers lead a healthier life through nutritional solutions from food and beverages to life-enhancing scientific products. Responding to increasing consumer needs, Nestlé extended its activities to include the field of specialized, medical skin treatments through the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a broad range of innovative and scientifically-proven products.
 

Consejo de gestión & Consejo de supervisión

CEO
Laurent Freixe
Consejo de gestión
Anna Manz, Béatrice Guillaume-Grabisch, David Rennie, Laurent Freixe, Leanne Geale, Sanjay Bahadur, Steven Wood Presley, Remy Ejel , David Xiqiang Zhang, Stefan Palzer, Bernard Meunier, Stephanie Pullings Hart, Anna Mohl, Guillaume Le Cunff, Lisa Gibby
Consejo de supervisión
Paul Bulcke, Dick Boer, Dinesh Paliwal, Hanne Jimenez de Mora, Lindiwe Majele Sibanda, Patrick Aebischer, Renato Fassbind, Luca Maestri, Chris Leong, Geraldine Matchett, Rainer Blair, Marie-Gabrielle Ineichen-Fleisch, Pablo Isla
 

Datos de la empresa

Nombre: Nestlé SA
Dirección: Avenue Nestlé 55,Vevey
Teléfono: +41-21-924-1111
Fax: +41-21-924-4800
E-mail: -
Internet: www.nestle.com/
Industria: Consumer Goods
Sector: Food and Beverage
Subsector: Food Products
Fin del año financiero: 31/12
Acciones de libre circulación: 96.83%
Fecha de OPI: 25/10/1905

Relación con inversores

Nombre: David Hancock
IR teléfono: +41 21 924 3509
IR-fax: +41 (21) 924 4800
IR e-mail: ir@nestle.com

Calendario de la empresa

CW 7 | 13/02/2025 Report 4th Quarter
CW 16 | 16/04/2025 General Shareholder Meeting
 

Accionistas mayoritarios

Otros
 
94.96%
BlackRock, Inc.
 
5.04%